Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Cell Culture market research products provide analysis of the latest trends, developments and market data for this industry. Research information will help you make informed business decisions.

older | 1 | .... | 3 | 4 | (Page 5) | 6 | 7 | .... | 17 | newer

    0 0

    Global High Throughput Screening (HTS) Market 2014-2018 About High Throughput Screening High throughput screening (HTS) is a technology of screening and analyzing a large number of biological or chemical compounds against specific targets. It is generally a fully automated technology and involves instruments, consumables, and software for screening and analysis of compound. The use of liquid handling devices, robotics, and bioinformatics are important aspects of the HTS technology. It is widely used by researchers for drug discovery and other research applications. The high sensitivity, high speed, and easy to use supports the adoption of HTS in research and drug discovery to identify enzymes, ligands for receptors, ion-channels, or other pharmacological targets of interest. HTS is a crucial step in drug discovery for various applications such as assay development, target identification, and primary screening. TechNavio's analysts forecast the Global HTS market to grow at a CAGR of 7.85 percent over the period 2013-2018. Covered in this Report This report covers the present scenario and the growth prospects of the Global HTS market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of instruments, consumables, and services used for HTS. It also includes the technologies used

    0 0
  • 08/31/14--22:00: Cell-Based Assays
  • Cell-Based Assays This report analyzes the worldwide markets for Cell-Based Assays in US$ Million by the following Applications: Basic Research, ADME Testing, and Drug Discovery. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 74 companies including many key and niche players such as - BD Biosciences Beckman Coulter, Inc. BioVision, Inc. Cisbio Bioassays DiscoveRx Corporation Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location. The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an

    0 0

    Global Cell and Tissue Analysis Products Market 2014-2018 About Cell and Tissue Analysis Products Cell and tissue analysis refers to the study of cells or tissues to identify and analyze the structure and function of cells and tissues. Various biospecimen preparation, cell and tissue separation, and cell and tissue characterization products are used to isolate and assess cells and tissue. The predominant technologies used in cell and tissue analysis are flow cytometry, HCS, and cell-based assays, which provide high efficiency and accuracy in research and other applications. Cell and tissue analysis products are used by various industries including Biotechnology, Pharmaceutical, Research, and CROs. It has wide-ranging applications in drug discovery and development, stem cell research, cell biology, and in other research practices. TechNavio's analysts forecast the Global Cell and Tissue Analysis Products market to grow at a CAGR of 6.28 percent over the period 2013-2018. Covered in this Report This report covers the present scenario and the growth prospects of the Global Cell and Tissue Analysis Products market for the period 2014-2018. To calculate the market size, the report considers revenue generated from sales of cell and tissue analysis products technologies, and products. The predominant technologies used in cell and tissue analysis are biospecimen

    0 0

    3D Cell Cultures: Technologies and Global Markets REPORT HIGHLIGHTS The three dimensional cell culture market was $438 million in 2013. This market is expected to grow to $586.1 million and about $2.2 billion in 2019, a compound annual growth rate(CAGR) of 30.1%. This report provides: An overview of the global markets and technologies for 3D cell cultures. Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019. Information on 3D technologies with a focus on representative platforms including cube, spherical droplet, stacked plate, magnetic bead, and other platforms. Value chain analysis at the following levels: key innovation or founding intellectual property, prototyping, beta testing, and research collaborations or reltationship building. Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities. Relevant patent analysis including recent activity and a list of key patents. Comprehensive profiles of major players in the industry.

    0 0

    Emerging Trends in Cell Banking (Technical Insights) Research Scope The execution of different test methods aiming to evaluate the stability and potency of biopharmaceutical products, as well as, their pharmacokinetic/pharmacodynamic (PK/PD) profiles, their characterization and comparison with other drugs, or the detection of antidrug antibodies (ADAs) or neutralizing antibodies (NAB), represent critical stages in drug discovery and development. On that note, cells and cell-based reagents constitute the foundations of most operational challenges. Indeed, cultured cells are frequently used to generate monoclonal antibodies (MAbs), enzymes, or substrates to be then utilized in other types of tests, such as ligand binding and enzymatic assays, thereby requiring distinct characterization and control measures to guarantee functional reliability over time. The extreme sensitivity of cellular components to different chemical and physical elements and the possibility of alterations in the proteome expression profiles hold significant importance in assessing biopharmaceutical products. Therefore, the need for homogeneous, stable cell banks capable of safeguarding starting cellular material is substantial to perform reliable cell-based assays. Master and working cell banks (MCBs and WCBs) are established with the aim to provide a continuous source of viable cells that allow to generate accurate results for specific test methods. This research service

    0 0

    Global Cell Culture Protein Surface Coating Market 2015-2019 About Cell Culture Protein Surface Coating Cell culture protein surface coating is a procedure in which the cell culture surfaces are coated with proteins or extracellular matrix components to enhance the adhesion and proliferation of the cells in vitro. The following are the different types of available proteins: human-derived proteins, animal-derived proteins, plant-derived proteins, and synthetic proteins. Proteins such as fibronectin, laminin, collagen, vitronectin, and osteopontin are used for cell culture protein surface coating. Protein surface coating helps in the growth of various types of cells such as endothelial, epithelial, fibroblasts, leukocytes, myoblasts and muscle cells, neurons, and CHO cell lines. Cell culture protein surface coating provides improved adhesion, proliferation, and rapid growth of cells during isolation and cultivation. TechNavio's analysts forecast the Global Cell Culture Protein Surface Coating market to grow at a CAGR of 12.91 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects of Global Cell Culture Protein Surface Coating market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of cell culture protein surface coating products including consumables and instruments. It includes the usage

    0 0
  • 12/31/14--21:00: Marine Biotechnology
  • Marine Biotechnology This report analyzes the worldwide markets for Marine Biotechnology in US$ Million. The Global market is further analyzed by the following Product Segments: Marine Biomaterials, Marine Bioactive Substances, and Others. The Major End-Use Applications analyzed are Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 84 companies including many key and niche players such as - Aker BioMarine AS Aqua Bio Technology ASA BASF SE CP Kelco Cyanotech Corp. Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing

    0 0

    The 2013-2018 Outlook for Cell/tissue Culture Sera in the United States This econometric study covers the latent demand outlook for cell/tissue culture Sera across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United States is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state and city, latent demand estimates are created for cell/tissue culture Sera. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all

    0 0

    The 2013-2018 Outlook for Cell/tissue Culture Supplies in the United States This econometric study covers the latent demand outlook for cell/tissue culture supplies across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United States is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state and city, latent demand estimates are created for cell/tissue culture supplies. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all

    0 0

    Global Markets for Media, Sera and Reagents in Biotechnology The global market for cell culture products will grow from nearly $3.2 billion in 2014 to nearly $4.1 billion by 2019 at a compound annual growth rate (CAGR) of 5.1% between 2014 and 2019. This report provides: An overview of the global markets and technologies for media, sera and reagents used in biotechnology. Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019. Information on different types of cell cultures and products from cell culture technology as well as the advantages and disadvantages for the use of various types of media are also covered. Detailed analysis of the cell culture industry's structure. Discussion covering the applications of cell culture technology with an emphasis on usage in the research, production and contract segments. Comprehensive profiles of major players in the media, sera, and reagents industry.

    0 0

    Cell Analysis Global Market – Forecast To 2020 Cell analysis plays a major role in gene identification, protein identification, transcription analysis and epigenomics at cellular level. It proves to be an ultra-sensitive device to elucidate specific molecular processes and pathways and reveal the nature of cell heterogenecity. Hospitals, academic institutions, government bodies, as well as pharmaceutical and biotechnology firms are increasing their focus on application of cell analysis as a modern emerging tool in research, drug discovery and diagnosis. The cell analysis techniques global market is segmented into molecular approaches, image-based approaches and others. The molecular approaches include the PCR, NGS and Microfluidics, cell isolation & separation techniques performed at cells genomic level, where as the image-based approaches include microscopes, FISH, FRAP, tracking, high content screening (HCS), cytometry techniques etc. The cell analysis products market is mainly segmented into consumables and instruments. The consumables include reagents, assay plates and microplates where as the instrument segment comprises of microscopes, flow cytometers, --**spectrophotometer, quantitative polymerase chain reaction (QPCR), microfluidic devices, cell counters, high content screening (HCS) systems and cell microarrays. By application, the market is segmented into by processes, by feild and by therapeutics. By processes is

    0 0

    Conference Documentation: Advances in Cell Based Assays SMi’s sixth Annual Biomarkers conference unites advances in biomarker use for drug discovery and development, alongside biomarkers for cancer. This two-day meeting showcases the best new opportunities and strategies to accelerate go/no-go decision making in early and clinical development. Key academic, government and industry figures cover topics encompassing: Case studies in idiopathic pulmonary fibrosis (IPF) and molecular characterisation of solid tumors Interactive panel discussion focusing on current developments in personalised medicine via biomarkers Latest advancements in molecular diagnostics and multi-centre clinical imaging studies New developments in pharmacogenetic and pharmacogenomic statistical study design Future direction and initiatives for safety biomarkers Maximise the cost-effectiveness of your companion diagnostic for end-users

    0 0

    The 2016-2021 World Outlook for Cell/tissue Culture Supplies This econometric study covers the world outlook for cell/tissue culture supplies across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for cell/tissue culture supplies. It also shows how the P.I.E.

    0 0

    The 2016-2021 World Outlook for Cell/tissue Culture Reagents This econometric study covers the world outlook for cell/tissue culture reagents across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for cell/tissue culture reagents. It also shows how the P.I.E.

    0 0

    The 2016-2021 World Outlook for Cell and Tissue Culture Supplies This econometric study covers the world outlook for cell and tissue culture supplies across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for cell and tissue culture supplies.

    0 0

    The 2016-2021 World Outlook for Cell/tissue Culture Sera This econometric study covers the world outlook for cell/tissue culture Sera across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for cell/tissue culture Sera. It also shows how the P.I.E.

    0 0

    The 2016-2021 World Outlook for Cell Culture Media This econometric study covers the world outlook for cell culture media across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for cell culture media. It also shows how the P.I.E.

    0 0

    The Global Fetal Bovine Serum Industry Report 2015 is a professional and in-depth study on the current state of the Fetal Bovine Serum industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Fetal Bovine Serum market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Fetal Bovine Serum industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. With 192 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    0 0

    Cell-Based Assays: World Industry and Market Prospects 2015-2025 Cellular testing for pharmaceuticals – how to discover that technology’s commercial potential What’s the future of technologies for screening cells? Now discover those technological and commercial predictions from 2015. Stay ahead there for data, benefiting your influence. For those medical tests, you explore sales results, R&D, opportunities and revenue forecasts. That new report by visiongain shows you what’s possible for cell-based assays and related applications to aid drug discovery and development. Those R&D tools change pharma, opening new possibilities. Find out how, discovering predicted trends, progress and gains. Use of cell lines in bioassays becomes more important. Read on, then, to explore cell assaying products and services for medicine, seeing how high their revenues can go. Forecasts and other analysis showing potential revenues from those bioassays That study’s purpose is forecasting cell testing sales to 2025 at overall world, submarket and national level. Does our work answer every question? No, though it assesses those technologies for research and development, showing there the money and potential gains. There avoid struggles to find information on bioassays. Hear what’s possible. Besides revenue predictions, our new analysis shows recent results,

    0 0

    Cell Culture: The Market for Media, Sera and Reagents The growth in biopharmaceuticals is creating an unprecedented increase in demand for cell culture products. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques.  This Kalorama Information report, Cell Culture; The Market for Media, Sera and Reagents , analyzes the world market for media, sera and reagents and the major trends and drivers.  It is the fifth time Kalorama Information has looked at this market since 2007. As growing cells for biopharmaceutical production is slow, expensive and complicated, optimizing cell culture development is of paramount concern to companies developing biopharmaceuticals. The report contains market size projections, product offerings of major companies, current culture practice trends and company market share. The report focuses on three segments of the cell culture market Media Market Different kinds of cells require different types of media. Serum based media are widely used to grow a broad range of animal cell types and cell lines such as Chinese hamster ovaries (CHO) or murine myeloma cells (NS0) cells.  This report provides market size and forecast to 2019 for the

older | 1 | .... | 3 | 4 | (Page 5) | 6 | 7 | .... | 17 | newer